Research programme: antibacterial therapeutics - Evotec SE/Global Antibiotic Research and Development Partnership
Alternative Names: Antibacterials - Evotec SE/Global Antibiotic Research and Development Partnership; Antibiotics - Evotec SE/Global Antibiotic Research and Development PartnershipLatest Information Update: 28 Apr 2023
At a glance
- Originator Evotec AG; Global Antibiotic Research and Development Partnership
- Developer Evotec SE; Global Antibiotic Research and Development Partnership
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 28 Apr 2023 No recent reports of development identified for research development in Bacterial-infections in Germany
- 28 Apr 2023 No recent reports of development identified for research development in Bacterial-infections in Switzerland
- 22 Mar 2019 Evotec and The Global Antibiotic Research and Development Partnership enter into a research collaboration to discover and develop antibacterials for the treatment of drug-resistant Bacterial infections